Mark Delaney E.'s Insider Trades & SAST Disclosures

Mark Delaney E.'s most recent trade in Quest Diagnostics, Inc. was a trade of 37 Common Stock done at an average price of $194.7 . Disclosure was reported to the exchange on April 20, 2026.

Share

Note

This is a custom search result for pattern Mark Delaney E..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Quest Diagnostics	Mark E. Delaney	SVP & Chief Commercial Officer		20 Apr 2026	37	11,901 (0%)	0%	194.7	7,204	Common Stock
Quest Diagnostics	Mark E. Delaney	SVP & Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 204.86 per share.	04 Mar 2026	5,682	14,190 (0%)	0%	204.9	1,164,015	Common Stock
Quest Diagnostics	Mark E. Delaney	SVP & Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 204.86 per share.	04 Mar 2026	2,326	11,864 (0%)	0%	204.9	476,504	Common Stock
Quest Diagnostics	Mark Delaney E.	SVP & Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Feb 2026	7,332	7,332	-		-	Non-Qualifed Stock Option (right to buy)
Quest Diagnostics	Mark Delaney E.	SVP & Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Feb 2026	1,586	9,116 (0%)	0%		0	Common Stock
Quest Diagnostics	Mark Delaney E.	SVP & Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 206.99 per share.	18 Feb 2026	230	8,681 (0%)	0%	207.0	47,608	Common Stock
Quest Diagnostics	Mark Delaney E.	SVP & Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.01 per share.	18 Feb 2026	205	8,911 (0%)	0%	210.0	43,052	Common Stock
Quest Diagnostics	Mark Delaney E.	SVP & Chief Commercial Officer		18 Feb 2026	15	8,696 (0%)	0%	183.5	2,753	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades